|
FDA deserves thanks, not scorn
|
Under scrutiny
Director of FDA holds one of the most difficult, thankless jobs in the world
The stakes are high with the FDA job. People and governments around the world look to the FDA to lead when it comes to deciding which drugs and devices are reasonably safe and adequately efficacious.
But the studies that the PDA must scrutinize to evaluate new drugs and devices are never perfect, never 100% complete, never large enough to detect all the possible adverse effects, an...
Related newspaper, magazine, and journal articles from HighBeam Research
|
REGULATORS OUTLINE ACTIONS TO OVERSEE DRUG FIRMS' CLAIMS FDA, SEC WOULD SHARE INFORMATION
The Boston Globe
; ... promising to make public all the negative news the FDA tells drug-development companies ... years to create and test, any scrap of news about the FDA's opinions during a drug ... in ImClone before it disclosed negative news about its drug's progress before the FDA ...
|
|
GRASSLEY: SENATOR SAYS FDA SHOULD STOP CITING A FRAUDULENT KETEK STUDY, SEEKS ACCESS TO INFORMATION
Capitol Hill Press Releases
; Capitol Hill Press Releases 05-16-2006 For Immediate Release Grassley: Senator says FDA should stop citing a fraudulent Ketek study, seeks access to information May 16, 2006 WASHINGTON Sen. Chuck Grassley said it's "mystifying" that the Food and Drug Administration continues to provide information
|
|
Dingell Questions Timing Of Drug Firm Inspection; FDA Action Labeled `Possible Retaliation'
The Washington Post
; A drug company whose president testified against the Food and Drug Administration in hearings this week was hit with an unexpected FDA inspection minutes after his testimony, suggesting the inspection was "possible retaliation" by the FDA, according to Rep. John D. Dingell (D-Mich chairman of the
|
|
Congress Provides Budget for FDA in Fiscal Year 2002.
American Family Physician
; ... Drug User Fees Act and Mammography Quality Standards Act fees, Certification Fund, and Export Fund. For more detailed information on the appropriation of these funds, visit the FDA Web site at http://www.fda.gov/bbs/topics/NEWS/2001/NEW00782.html.
|
|
FDA Dependence on Drug Industry
Journal of the National Medical Association
; The opinions expressed here are not necessarily the opinions of the National Medical Association. In 1992, in an effort to speed up drug approvals, Congress authorized the FDA to collect funds from the brand-name drug manufacturers for five years.1 This law was extended for another five years in
|
